Olga Perez, MD
Family Medicine · Hialeah, FLNPI 1043487218
Payments from drug & device makers
Across 247 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$915
- Lilly USA, LLC$792
- AbbVie$359
- Amarin Pharma, Inc.$335
- AstraZeneca$280
- Pfizer$245
- plus $1K from 28 others
What the payments were for
- Food & beverage$4,144100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 58 | $915 |
| Lilly USA, LLC | 50 | $792 |
| AbbVie(2 entities) | 20 | $359 |
| Amarin Pharma, Inc. | 21 | $335 |
| AstraZeneca | 15 | $280 |
| Pfizer | 13 | $245 |
| GSK | 10 | $192 |
| Kowa Pharmaceuticals America, Inc. | 8 | $125 |
| Redhill Biopharma Inc. | 6 | $97 |
| Gilead | 5 | $81 |
| Amgen(2 entities) | 4 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Biohaven Pharmaceuticals, Inc. | 3 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $48 |
| Boston Scientific | 1 | $44 |
| Currax Pharmaceuticals LLC | 3 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $43 |
| Arbor Pharmaceuticals, Inc. | 3 | $42 |
| Abbott | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Eisai Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Antares Pharma, Inc. | 1 | $23 |
| Viiv Healthcare Company | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $15 |
| Zimmer Biomet | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Avion Pharmaceuticals | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$4,161 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 72 | $92,138 |
| OzempicSemaglutide | 83 | $90,268 |
| JardianceEmpagliflozin | 44 | $59,222 |
| LinzessLinaclotide | 24 | $24,456 |
| EliquisApixaban | 25 | $17,779 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $17,662 |
| LivaloPitavastatin Calcium | 19 | $11,303 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $9,878 |
| MyrbetriqMirabegron | 12 | $9,322 |
| Dexlansoprazole DrDexlansoprazole | 23 | $6,222 |
| Omega-3 Acid Ethyl Esters | 33 | $4,734 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $4,642 |
| SynthroidLevothyroxine Sodium | 29 | $3,972 |
| Gabapentin | 154 | $2,590 |
| Omeprazole | 102 | $2,522 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $792 | $92,13872 claims |
| Novo NordiskOzempic | $915 | $90,26883 claims |
| AbbVieLinzess, Synthroid | $359 | $28,42753 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $192 | $27,53938 claims |
| PfizerEliquis | $245 | $17,77925 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $125 | $11,30319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Hialeah
- Dario AltamiranoHialeah$15.5M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.